Patent · US Active

Spliceostatin analogs and methods for their preparation

US9764040B2 · kind B2 · utility

0Cited by

9References

2Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Chakrapani Subramanyam · South Glastonbury, US
Frank Koehn · Fort Pierce, US
Kenneth John Dirico · Gales Ferry, US
Alessandra S. Eustaquio · Old Saybrook, US
Michael Eric Green · Boston, US
Haiyin He · Hackettstown, US
Min He · Dongguan, CN
Christopher John O'Donnell · Mystic, US
Sujiet Puthenveetil · Attleboro, US
Anokha Ratnayake · Mystic, US
Jesse A. Teske · Westerly, US
Hui Yu Yang · Newton, US

Key dates

Filing date	Sep 29, 2016
Grant date	Sep 19, 2017
Priority date	—
Expiry date	Sep 29, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D493/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to novel cytotoxic spliceostatin analogs and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.